<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01567150</url>
  </required_header>
  <id_info>
    <org_study_id>5064-W</org_study_id>
    <nct_id>NCT01567150</nct_id>
  </id_info>
  <brief_title>Wound Fluid Protease Levels During Use of Novel Wound Dressing</brief_title>
  <official_title>Wound Fluid Protease Levels During Use of Novel Wound Dressing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hollister Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hollister Incorporated</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is being conducted to characterize the way leg wounds respond to a new type of
      wound dressing, compared to wounds in patients who are not using the new dressing. The
      investigators will collect wound fluid for biochemical analysis, and they will measure the
      wound healing that occurs with and without the new dressing.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Abnormal wound healing is characterized by prolonged inflammation and excess degradation of
      the extracellular matrix through the activity of proteinases and other enzymes. Wound fluids
      can provide biochemical information about the healing status of chronic wounds and the
      effects of wound treatments. In this study the investigators will obtain samples of wound
      fluid and measure healing in wounds randomized to receive the novel dressing or a control.
      The findings will be compared between the two groups.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Actual">January 2014</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Matrix Metalloproteinase Level in Wound Fluid</measure>
    <time_frame>8 weeks</time_frame>
    <description>Wound fluid will be collected and analyzed at baseline and approximately every 7 days.
Mean was calculated for each subject. Means and standard deviation were calculated for the treatment and control groups.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Wound Healing</measure>
    <time_frame>12 weeks</time_frame>
    <description>change in wound area mean was calculated for each subject Mean and sd were calculated for each group</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">35</enrollment>
  <condition>Venous Stasis Ulcers</condition>
  <arm_group>
    <arm_group_label>novel dressing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Treatment with novel dressing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control is treatment without novel dressing</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Novel Dressing</intervention_name>
    <description>Topical wound dressing</description>
    <arm_group_label>novel dressing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of venous insufficiency

          -  One or more partial or full-thickness venous leg ulcers 5-24 sq. cm in size without
             evidence of clinical infection

          -  Ankle/brachial index 0.8 and above

          -  Duration of wound up to one year

          -  Able to return to wound clinic for weekly evaluations

          -  Has signed Institutional Review Board approved informed consent

        Exclusion Criteria:

          -  Exposed bone or tendon or necrotic wound base

          -  Signs or symptoms of cellulitis or osteomyelitis at the target ulcer

          -  Allergy to a component of the novel dressing or compression wrap

          -  Third degree burn

          -  Vasculitis, severe rheumatoid arthritis or other collagen vascular disease

          -  Receiving antibiotics

          -  Pregnant or lactating
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ginger Salvadalena, PhD, RN</last_name>
    <role>Study Director</role>
    <affiliation>Hollister Incorporated</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Arizona Heart Hospital</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85006</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Phoenix Baptist Hospital</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85015</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Miami, Department of Surgery, Div. of Vascular Surgery</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alexian Brothers Medical Center Wound Healing Center</name>
      <address>
        <city>Elk Grove Village</city>
        <state>Illinois</state>
        <zip>60007</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Genesys Regional Medical Center</name>
      <address>
        <city>Grand Blanc</city>
        <state>Michigan</state>
        <zip>48439</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NYU Langone Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Circleville Foot &amp; Ankle</name>
      <address>
        <city>Circleville</city>
        <state>Ohio</state>
        <zip>43113</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baylor University Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75246</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 23, 2012</study_first_submitted>
  <study_first_submitted_qc>March 28, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 30, 2012</study_first_posted>
  <results_first_submitted>September 22, 2015</results_first_submitted>
  <results_first_submitted_qc>October 4, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 25, 2016</results_first_posted>
  <last_update_submitted>October 4, 2016</last_update_submitted>
  <last_update_submitted_qc>October 4, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postphlebitic Syndrome</mesh_term>
    <mesh_term>Postthrombotic Syndrome</mesh_term>
    <mesh_term>Varicose Ulcer</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>4 subjects attended only one study visit thus did not have evaluable data</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Novel Dressing</title>
          <description>Treatment with novel dressing
Novel Dressing: Topical wound dressing</description>
        </group>
        <group group_id="P2">
          <title>Control</title>
          <description>Control is treatment without novel dressing</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Novel Dressing</title>
          <description>Treatment with novel dressing
Novel Dressing: Topical wound dressing</description>
        </group>
        <group group_id="B2">
          <title>Control</title>
          <description>Control is treatment without novel dressing</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="19"/>
            <count group_id="B2" value="16"/>
            <count group_id="B3" value="35"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56.1" spread="14.9"/>
                    <measurement group_id="B2" value="60.6" spread="12.9"/>
                    <measurement group_id="B3" value="58.1" spread="14.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Matrix Metalloproteinase Level in Wound Fluid</title>
        <description>Wound fluid will be collected and analyzed at baseline and approximately every 7 days.
Mean was calculated for each subject. Means and standard deviation were calculated for the treatment and control groups.</description>
        <time_frame>8 weeks</time_frame>
        <population>Overall mean across 8 week timeframe</population>
        <group_list>
          <group group_id="O1">
            <title>Novel Dressing</title>
            <description>Treatment with novel dressing
Novel Dressing: Topical wound dressing</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Control is treatment without novel dressing</description>
          </group>
        </group_list>
        <measure>
          <title>Matrix Metalloproteinase Level in Wound Fluid</title>
          <description>Wound fluid will be collected and analyzed at baseline and approximately every 7 days.
Mean was calculated for each subject. Means and standard deviation were calculated for the treatment and control groups.</description>
          <population>Overall mean across 8 week timeframe</population>
          <units>mcg/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.71" spread="0.78"/>
                    <measurement group_id="O2" value="0.88" spread="0.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Wound Healing</title>
        <description>change in wound area mean was calculated for each subject Mean and sd were calculated for each group</description>
        <time_frame>12 weeks</time_frame>
        <population>average across 12 week time frame</population>
        <group_list>
          <group group_id="O1">
            <title>Novel Dressing</title>
            <description>Treatment with novel dressing
Novel Dressing: Topical wound dressing</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Control is treatment without novel dressing</description>
          </group>
        </group_list>
        <measure>
          <title>Wound Healing</title>
          <description>change in wound area mean was calculated for each subject Mean and sd were calculated for each group</description>
          <population>average across 12 week time frame</population>
          <units>square cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.99" spread="8.22"/>
                    <measurement group_id="O2" value="-2.49" spread="6.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Up to 12 weeks</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Novel Dressing</title>
          <description>Treatment with novel dressing
Novel Dressing: Topical wound dressing</description>
        </group>
        <group group_id="E2">
          <title>Control</title>
          <description>Control is treatment without novel dressing</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Director, Global Clinical Affairs</name_or_title>
      <organization>Hollister Incorporated</organization>
      <phone>8479183996</phone>
      <email>ginger.salvadalena@hollister.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

